MinichMacGregor Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-19
Closed -$1K 362
2018
Q3
$1K Sell
19
-17
-47% -$1.26K ﹤0.01% 488
2018
Q2
$2K Sell
36
-18
-33% -$1.24K ﹤0.01% 445
2018
Q1
$3K Buy
54
+12
+29% +$914 ﹤0.01% 407
2017
Q4
$3K Buy
42
+5
+14% +$377 ﹤0.01% 398
2017
Q3
$2K Buy
37
+17
+85% +$1.28K ﹤0.01% 398
2017
Q2
$1K Hold
20
﹤0.01% 440
2017
Q1
$1K Hold
20
﹤0.01% 429
2016
Q4
$1K Hold
20
﹤0.01% 429
2016
Q3
$1K Sell
20
-2
-9% -$146 ﹤0.01% 428
2016
Q2
$1K Hold
22
﹤0.01% 409
2016
Q1
$1K Buy
+22
New +$1.5K ﹤0.01% 394

Other funds holding NVS

MinichMacGregor Wealth Management's NVS Position: Q4 2018 in Review

MinichMacGregor Wealth Management sold out of Novartis (NVS) in Q4 2018, closing a stake of 19 shares — an estimated $1K sold.

MinichMacGregor Wealth Management first reported a position in NVS in Q1 2016 and held it in 11 quarters. The position peaked at $3K in Q1 2018. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

  • MinichMacGregor Wealth Management reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 19 Novartis shares in Q4 2018, an estimated $1K.
  • MinichMacGregor Wealth Management first reported a position in Novartis in Q1 2016 and held it in 11 quarters.
  • MinichMacGregor Wealth Management's Novartis position peaked at $3K in Q1 2018.
  • 1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on MinichMacGregor Wealth Management's 13F filing for Q4 2018, filed 17 Jan 2019.